ANDEXANET ALFA (Ondexxya®)
Clinical Indication
Reversing anticoagulation from apixaban or rivaroxaban in adults for life-threatening or uncontrolled GI bleed.
Comments
In line with NICE TA697
Date of classification
August 2021
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.